Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,190 Cr
up ₹133 Cr vs Jun 2025
- Stocks held
- 29
- unchanged
- Top 10 weight
- 62.4%
- of the portfolio in its ten largest
- Cash & debt
- 1.8%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 10
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In July 2025 it disclosed 29 stocks worth ₹3,190 Cr, up ₹133 Cr from Jun 2025. Its largest positions were Cipla Limited (8.7%), Sun Pharmaceutical Industries Limited (8.2%), IPCA Laboratories Limited (7.8%); the ten largest together made up 62.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 67.5% of its equity. Cash and debt stood at 1.8%. Compared with Jun 2025 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
88%
Top-10 weight is higher than 88% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
29%
Holds more cash than 29% of peers
Holdings in July 2025
Download CSVEvery line the fund disclosed, with the change against Jun 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.73%
- Δ weight
- down 0.10 pts
- Value
- ₹278 Cr
- Δ value
- up ₹8.7 Cr
- Status
- Added
- Weight
- 8.22%
- Δ weight
- down 0.20 pts
- Value
- ₹262 Cr
- Δ value
- up ₹4.8 Cr
- Status
- Added
- Weight
- 7.84%
- Δ weight
- up 0.13 pts
- Value
- ₹250 Cr
- Δ value
- up ₹14.3 Cr
- Status
- Added
- Weight
- 7.79%
- Δ weight
- down 0.09 pts
- Value
- ₹249 Cr
- Δ value
- up ₹7.6 Cr
- Status
- Added
- Weight
- 6.08%
- Δ weight
- up 0.82 pts
- Value
- ₹194 Cr
- Δ value
- up ₹33.2 Cr
- Status
- Added
- Weight
- 5.96%
- Δ weight
- up 0.44 pts
- Value
- ₹190 Cr
- Δ value
- up ₹21.3 Cr
- Status
- Added
- Weight
- 4.58%
- Δ weight
- down 0.04 pts
- Value
- ₹146 Cr
- Δ value
- up ₹5 Cr
- Status
- Added
- Weight
- 4.52%
- Δ weight
- up 0.24 pts
- Value
- ₹144 Cr
- Δ value
- up ₹13.3 Cr
- Status
- Added
- Weight
- 4.38%
- Δ weight
- down 0.48 pts
- Value
- ₹140 Cr
- Δ value
- down ₹8.7 Cr
- Status
- Trimmed
- Weight
- 4.32%
- Δ weight
- up 0.01 pts
- Value
- ₹138 Cr
- Δ value
- up ₹6 Cr
- Status
- Added
- Weight
- 3.88%
- Δ weight
- down 0.56 pts
- Value
- ₹124 Cr
- Δ value
- down ₹11.8 Cr
- Status
- Trimmed
- Weight
- 3.27%
- Δ weight
- down 0.46 pts
- Value
- ₹104 Cr
- Δ value
- down ₹9.7 Cr
- Status
- Trimmed
- Weight
- 3.23%
- Δ weight
- up 0.08 pts
- Value
- ₹103 Cr
- Δ value
- up ₹6.7 Cr
- Status
- Added
- Weight
- 3.22%
- Δ weight
- down 0.14 pts
- Value
- ₹103 Cr
- Δ value
- up ₹8 L
- Status
- Held
- Weight
- 3.15%
- Δ weight
- up 0.14 pts
- Value
- ₹101 Cr
- Δ value
- up ₹8.4 Cr
- Status
- Added
- Weight
- 2.94%
- Δ weight
- down 0.12 pts
- Value
- ₹93.9 Cr
- Δ value
- up ₹24 L
- Status
- Held
- Weight
- 2.71%
- Δ weight
- down 0.23 pts
- Value
- ₹86.6 Cr
- Δ value
- down ₹3.5 Cr
- Status
- Trimmed
- Weight
- 2.48%
- Δ weight
- down 0.38 pts
- Value
- ₹79.1 Cr
- Δ value
- down ₹8.2 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.84%
- Δ weight
- up 0.74 pts
- Value
- ₹58.6 Cr
- Δ value
- up ₹25 Cr
- Status
- Added
- Weight
- 1.74%
- Δ weight
- up 0.29 pts
- Value
- ₹55.4 Cr
- Δ value
- up ₹11.1 Cr
- Status
- Added
- Weight
- 1.67%
- Δ weight
- up 0.02 pts
- Value
- ₹53.1 Cr
- Δ value
- up ₹2.9 Cr
- Status
- Added
- Weight
- 1.46%
- Δ weight
- down 0.15 pts
- Value
- ₹46.5 Cr
- Δ value
- down ₹2.7 Cr
- Status
- Trimmed
- Weight
- 1.35%
- Δ weight
- up 0.08 pts
- Value
- ₹43.2 Cr
- Δ value
- up ₹4.1 Cr
- Status
- Added
- Weight
- 1.09%
- Δ weight
- down 0.11 pts
- Value
- ₹34.9 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
- Weight
- 0.95%
- Δ weight
- up 0.21 pts
- Value
- ₹30.4 Cr
- Δ value
- up ₹7.7 Cr
- Status
- Added
- Weight
- 0.59%
- Δ weight
- down 0.01 pts
- Value
- ₹18.8 Cr
- Δ value
- up ₹34 L
- Status
- Added
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.58%
- Δ weight
- up 0.01 pts
- Value
- ₹18.6 Cr
- Δ value
- up ₹93 L
- Status
- Added
- Weight
- 0.56%
- Δ weight
- down 0.01 pts
- Value
- ₹17.9 Cr
- Δ value
- up ₹50 L
- Status
- Added
- Weight
- 0.42%
- Δ weight
- down 0.04 pts
- Value
- ₹13.5 Cr
- Δ value
- down ₹63 L
- Status
- Trimmed
- Weight
- 0.37%
- Δ weight
- down 0.03 pts
- Value
- ₹11.8 Cr
- Δ value
- down ₹35 L
- Status
- Trimmed
- Weight
- 0.08%
- Δ weight
- down 0.04 pts
- Value
- ₹2.6 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
What changed, Jun 2025 to Jul 2025
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Laurus Labs Limitedup ₹33.2 Cr (+0.82% pts)
- Gland Pharma Limitedup ₹21.3 Cr (+0.44% pts)
- IPCA Laboratories Limitedup ₹14.3 Cr (+0.13% pts)
- Illumina Incup ₹13.3 Cr (+0.24% pts)
- Emcure Pharmaceuticals Limitedup ₹11.1 Cr (+0.29% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jun 2025, the weight rose most in Healthcare Services (+0.7 pts) and Pharmaceuticals & Biotechnology (+0.6 pts), and fell most in Healthcare Equipment & Supplies (−0.9 pts) and Pharmaceuticals (−0.2 pts).
- Healthcare Services16.7% → 17.4%+0.7 pts
- Pharmaceuticals & Biotechnology67.0% → 67.5%+0.6 pts
- Healthcare Equipment & Supplies7.8% → 6.9%−0.9 pts
- Pharmaceuticals6.3% → 6.1%−0.2 pts
- Insurance1.6% → 1.5%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jul 2022 | Jul 2024 | Jan 2025 | Apr 2025 | Jun 2025 | Jul 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 57.0% | 69.7% | 63.7% | 65.9% | 67.0% | 67.5% |
| Healthcare Services | 26.0% | 14.6% | 18.9% | 17.6% | 16.7% | 17.4% |
| Healthcare Equipment & Supplies | 5.6% | 8.0% | 10.2% | 8.9% | 7.8% | 6.9% |
| Pharmaceuticals | 7.7% | 5.4% | 5.3% | 5.6% | 6.3% | 6.1% |
| Insurance | 2.5% | 1.8% | 1.4% | 1.6% | 1.6% | 1.5% |
| Retailing | 1.2% | 0.5% | 0.4% | 0.5% | 0.6% | 0.6% |
Allocation in Jul 2025change vs Jun 2025
- Pharmaceuticals & Biotechnology (14)67.5%▲ 0.6 pts
- Healthcare Services (7)17.4%▲ 0.7 pts
- Healthcare Equipment & Supplies (3)6.9%▼ 0.9 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jul 2025
1.8%
▲ 0.7 pts vs Jun 2025
- Cash alone
- 1.8%
- cash and net receivables
- A year earlier
- 3.3%
- Jul 2024 · now ▼ 1.5 pts
- Last 12 months
- 0.1% – 5.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.